๐ข Recruiting
Phase 2
๐ Investigational Drug / Biologic
NCT06614322
SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.
๐ Beth Israel Deaconess Medical Center for Autonomic and Peripheral Nerve Disorders โ Boston, Massachusetts
View Study & Checklist โ